المؤلفون: Zheng X; Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China; Department of Radiation Oncology, Anhui Provincial Cancer Hospital, Hefei 230031, China., Liu K; Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China; Department of Radiology, The First Affiliated Hospital of University of Science and Technology of China, Hefei 230001, China., Shen N; Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China., Gao Y; Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China., Zhu C; Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China., Li C; Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China., Rong C; Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China., Li S; Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China., Qian B; Huiying Medical Technology, Beijing 100192, China., Li J; CT Advanced Application, GE HealthCare China, Beijing 100186, China., Wu X; Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China. Electronic address: duobi2004@126.com.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jun; Vol. 195, pp. 110221. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Deep Learning* , Small Cell Lung Carcinoma*/radiotherapy , Small Cell Lung Carcinoma*/mortality , Small Cell Lung Carcinoma*/diagnostic imaging , Small Cell Lung Carcinoma*/pathology , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/mortality , Lung Neoplasms*/pathology , Lung Neoplasms*/diagnostic imaging , Tomography, X-Ray Computed*/methods , Cranial Irradiation*/methods, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Survival Rate

المؤلفون: Lee Y; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Pathology, Chungnam National University College of Medicine, Daejeon, South Korea., Lee B; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: boram.lee.1103@gmail.com., Choi YL; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea. Electronic address: ylachoi@skku.edu., Kang DW; Department of Pathology, Chungnam National University College of Medicine, Daejeon, South Korea., Han J; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

المصدر: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Jun; Vol. 37 (6), pp. 100490. Date of Electronic Publication: 2024 Apr 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Receptor, ErbB-2*/genetics , Receptor, ErbB-2*/metabolism , Precision Medicine* , Mutation* , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/analysis, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Immunohistochemistry ; High-Throughput Nucleotide Sequencing ; Gene Amplification

المؤلفون: Martin A; Palliative care Department, Institut Curie, Paris, France., Carton M; Biostatistics Department, Institut Curie, Paris, France., Thery L; Palliative care Department, Institut Curie, Paris, France., Burnod A; Palliative care Department, Institut Curie, Paris, France., Daniel C; Oncology Department, Institut Curie, Paris, France., Du Rusquec P; Oncology Department, Institut Curie, Paris, France., Girard N; Oncology Department, Institut Curie, Paris, France., Bouleuc C; Supportive care Department, Institut Curie, Paris, France. Electronic address: carole.bouleuc@curie.fr.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Jun; Vol. 192, pp. 107800. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Palliative Care*/methods , Lung Neoplasms*/therapy , Lung Neoplasms*/mortality , Lung Neoplasms*/pathology , Terminal Care*/methods , Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/drug therapy, Humans ; Male ; Female ; Aged ; Middle Aged ; Aged, 80 and over ; Cohort Studies

المؤلفون: Wang D; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.; Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, 200032, P. R. China.; Center for Biomedical Imaging, Fudan University, Shanghai, 200032, P. R. China., Wang S; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.; Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, 200032, P. R. China.; Center for Biomedical Imaging, Fudan University, Shanghai, 200032, P. R. China.; Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China., Jin M; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, P. R. China.; Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, 201318, P. R. China., Zuo Y; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.; Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, 200032, P. R. China.; Center for Biomedical Imaging, Fudan University, Shanghai, 200032, P. R. China., Wang J; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, 150007, P. R. China., Niu Y; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China., Zhou Q; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China., Chen J; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China., Tang X; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China., Tang W; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; School of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China., Liu X; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, P. R. China.; Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, 201318, P. R. China., Yu H; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China., Yan W; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.; Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China., Wei HH; Bio-med Big Data Center, Chinese Academy of Sciences Key Laboratory of Computational Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Nutrition and Health, Shanghai, 200031, P. R. China., Huang G; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, P. R. China.; Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, 201318, P. R. China., Song S; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.; Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, 200032, P. R. China.; Center for Biomedical Imaging, Fudan University, Shanghai, 200032, P. R. China., Tang S; Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, 200032, P. R. China.

المصدر: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Jun; Vol. 11 (22), pp. e2309857. Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/metabolism , Carcinoma, Non-Small-Cell Lung*/pathology , Exosomes*/metabolism , Exosomes*/genetics , Lung Neoplasms*/genetics , Lung Neoplasms*/metabolism , Lung Neoplasms*/pathology , Macrophages*/metabolism , RNA, Circular*/genetics , RNA, Circular*/metabolism , Tumor Microenvironment*/genetics, Animals ; Humans ; Mice ; Cell Line, Tumor ; Disease Models, Animal ; Neoplasm Metastasis/genetics ; Mice, Nude

المؤلفون: Tsukita Y; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan., Taguri M; Department of Health Data Science, Tokyo Medical University, Tokyo, Japan., Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Hosomi Y; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Mizutani T; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan., Watanabe K; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Yoh K; Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan., Takahashi S; Department of Thoracic Surgery, Tokyo Medical University, Tokyo, Japan., Kubota K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan., Kunitoh H; Department of Chemotherapy, Japan Red Cross Medical Center, Tokyo, Japan.

المصدر: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Jun 01; Vol. 54 (6), pp. 730-734.

نوع المنشور: Journal Article; Multicenter Study; Clinical Trial Protocol

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Aniline Compounds*/administration & dosage , Aniline Compounds*/therapeutic use , Acrylamides*/administration & dosage , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , ErbB Receptors*/genetics , Mutation*, Humans ; Aged ; Female ; Male ; Aged, 80 and over ; Dose-Response Relationship, Drug ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/therapeutic use ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Progression-Free Survival ; Indoles ; Pyrimidines

المؤلفون: Waliany S; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Neal JW; Stanford University Medical Center, Stanford, CA., Engel-Nitz N; Optum Life Sciences, Eden Prairie, MN., Lam C; AstraZeneca Pharmaceuticals LP, Gaithersburg, MD., Lin F; Daiichi Sankyo, Inc., Basking Ridge, NJ., Park L; AstraZeneca Pharmaceuticals LP, Gaithersburg, MD., Le L; Optum Life Sciences, Eden Prairie, MN., Nagasaka M; University of California Irvine School of Medicine, Orange, CA. Electronic address: nagasakm@hs.uci.edu.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2024 Jun; Vol. 25 (4), pp. 319-328.e1. Date of Electronic Publication: 2024 Jan 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/mortality , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , Receptor, ErbB-2*/genetics , Receptor, ErbB-2*/metabolism , Electronic Health Records* , Mutation*, Humans ; Female ; Male ; Middle Aged ; Aged ; Retrospective Studies ; United States ; Practice Patterns, Physicians'/statistics & numerical data ; Treatment Outcome ; Databases, Factual ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Neoplasm Metastasis ; Survival Rate

المؤلفون: Li L; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., He K; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Zhou T; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Xu Y; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., China., Pang J; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., China., Yu Q; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Gao Y; Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Shi H; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Zhu H; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Li M; Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Yu J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.; Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.; Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences, Jinan, China., Yuan S; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.; Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

المصدر: Molecular oncology [Mol Oncol] 2024 Jun; Vol. 18 (6), pp. 1649-1664. Date of Electronic Publication: 2024 Feb 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/surgery , Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/metabolism , Lung Neoplasms*/pathology , Lung Neoplasms*/genetics , Lung Neoplasms*/surgery , Neoplasm Recurrence, Local*/genetics , Neoplasm Recurrence, Local*/pathology, Humans ; Female ; Middle Aged ; Male ; Prognosis ; Aged ; Margins of Excision ; Disease-Free Survival ; Neoplasm Staging ; Mutation ; Adult ; High-Throughput Nucleotide Sequencing

المؤلفون: Suzuki T; Division of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan., Deguchi S; Division of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan. Electronic address: s.deguchi@scchr.jp., Matsushima K; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan., Katsumata S; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan., Kojima H; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan., Koki M; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan., Konno H; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan., Isaka M; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan., Oishi T; Division of Diagnostic Pathology, Shizuoka Cancer Center, Shizuoka, Japan., Ohde Y; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan., Sugino T; Division of Diagnostic Pathology, Shizuoka Cancer Center, Shizuoka, Japan., Mitsuya K; Division of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan., Hayashi N; Division of Neurosurgery, Shizuoka Cancer Center, Shizuoka, Japan.

المصدر: World neurosurgery [World Neurosurg] 2024 Jun; Vol. 186, pp. e353-e359. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Journal Article; Review; Case Reports

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101528275 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-8769 (Electronic) Linking ISSN: 18788750 NLM ISO Abbreviation: World Neurosurg Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/secondary , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/mortality , Brain Neoplasms*/secondary , Brain Neoplasms*/mortality , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality, Humans ; Male ; Middle Aged ; Female ; Disease-Free Survival ; Adult ; Aged ; Craniotomy ; Mutation ; Neoplasm Recurrence, Local/pathology

المؤلفون: Hori T; Department of Pharmacy, Nara Prefecture General Medical Center, 2-897-5 Shichijo-nishimachi, Nara, 630-8581, Japan.; Department of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan., Yamamoto K; Department of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. yamakz@med.kobe-u.ac.jp., Ito T; Department of Respiratory Medicine, Nara Prefecture General Medical Center, 2-897-5 Shichijo-nishimachi, Nara, 630-8581, Japan., Ikushima S; Department of Pharmacy, Nara Prefecture General Medical Center, 2-897-5 Shichijo-nishimachi, Nara, 630-8581, Japan., Omura T; Department of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan., Yano I; Department of Pharmacy, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.

المصدر: Investigational new drugs [Invest New Drugs] 2024 Jun; Vol. 42 (3), pp. 281-288. Date of Electronic Publication: 2024 Mar 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Acrylamides*/therapeutic use , Acrylamides*/administration & dosage , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , ErbB Receptors*/genetics , Aniline Compounds*/administration & dosage , Aniline Compounds*/therapeutic use , Aniline Compounds*/adverse effects , Mutation*, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Aged, 80 and over ; Adult ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Progression-Free Survival ; Indoles ; Pyrimidines

المؤلفون: Wang Y; Department of Respiratory and Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, 510317, Guangdong, China., Jiang XY; Department of Respiratory and Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, 510317, Guangdong, China., Qu MY; Department of Respiratory and Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, 510317, Guangdong, China., Liang J; Department of Respiratory and Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, 510317, Guangdong, China., Yang JS; Department of Respiratory and Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, 510317, Guangdong, China., Sun RL; Department of Respiratory and Critical Care Medicine, Guangdong Second Provincial General Hospital, Guangzhou, 510317, Guangdong, China. sunruilin213@126.com.

المصدر: Biochemical genetics [Biochem Genet] 2024 Jun; Vol. 62 (3), pp. 1994-2009. Date of Electronic Publication: 2023 Oct 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 0126611 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4927 (Electronic) Linking ISSN: 00062928 NLM ISO Abbreviation: Biochem Genet Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/metabolism , MicroRNAs*/genetics , MicroRNAs*/metabolism , HMGB1 Protein*/genetics , HMGB1 Protein*/metabolism , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Lung Neoplasms*/metabolism , Cell Movement* , Neoplasm Invasiveness* , Potassium Channels, Voltage-Gated*/genetics , Potassium Channels, Voltage-Gated*/metabolism , Signal Transduction*, Humans ; RNA, Long Noncoding/genetics ; RNA, Long Noncoding/metabolism ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor ; A549 Cells